Matos Tiago R, Liu Hongye, Ritz Jerome
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Academic Medical Center, Department of Dermatology, University of Amsterdam, Amsterdam, The Netherlands.
Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
J Invest Dermatol. 2017 May;137(5):e43-e51. doi: 10.1016/j.jid.2017.03.002.
Mass cytometry by time-of-flight experiments allow analysis of over 40 functional and phenotypic cellular markers simultaneously at the single-cell level. The data dimensionality escalation accentuates limitations, inherent to manual analysis, as being subjective, labor-intensive, slow, and often incapable of showing the detailed features of each unique cell within populations. The subsequent challenge of examining, visualizing, and presenting mass cytometry data has motivated continuous development of dimensionality reduction methods. As a result, an increasing recognition of the inherent diversity and complexity of cellular networks is emerging, with the discovery of unexpected cell subpopulations, hierarchies, and developmental pathways, such as those existing within the immune system. Here, we briefly review some frequently used and accessible mass cytometry data analysis tools, including principal component analysis (PCA); spanning-tree progression analysis of density-normalized events (SPADE); t-distributed stochastic neighbor embedding (t-SNE)-based visualization (viSNE); automatic classification of cellular expression by nonlinear stochastic embedding (ACCENSE); and cluster identification, characterization, and regression (CITRUS). Mass cytometry, used together with these innovative analytic tools, has the power to lead to key discoveries in investigative dermatology, including but not limited to identifying signaling phenotypes with predictive value for early diagnosis, prognosis, or relapse and a thorough characterization of intratumor heterogeneity and disease-resistant cell populations, that may ultimately unveil novel therapeutic approaches.
飞行时间质谱流式细胞术实验能够在单细胞水平上同时分析40多种功能和表型细胞标志物。数据维度的增加凸显了手动分析固有的局限性,即主观、劳动强度大、速度慢,且往往无法显示群体中每个独特细胞的详细特征。随后,在检查、可视化和呈现质谱流式细胞术数据方面所面临的挑战推动了降维方法的不断发展。因此,人们越来越认识到细胞网络固有的多样性和复杂性,同时也发现了意想不到的细胞亚群、层次结构和发育途径,比如免疫系统中存在的那些。在这里,我们简要回顾一些常用且易于获取的质谱流式细胞术数据分析工具,包括主成分分析(PCA);密度归一化事件的生成树递进分析(SPADE);基于t分布随机邻域嵌入(t-SNE)的可视化(viSNE);通过非线性随机嵌入进行细胞表达自动分类(ACCENSE);以及聚类识别、表征和回归(CITRUS)。质谱流式细胞术与这些创新分析工具一起使用,有能力在皮肤研究领域带来关键发现,包括但不限于识别对早期诊断、预后或复发具有预测价值的信号表型,以及全面表征肿瘤内异质性和抗病细胞群体,这最终可能揭示新的治疗方法。